Reported Jun 1, 2022 · Terminated
Tivicay (dolutegravir) Tablets 50 mg, 30-count Bottle, Rx Only, Manufactured for: ViiV Healthcare RTP, NC 27709, NDC…
GlaxoSmithKline LLC
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: GlaxoSmithKline LLC · 1011 N Arendell Ave · Zebulon, NC · 27597-2309
Is this the product you have?
Tivicay (dolutegravir) Tablets 50 mg30-count BottleRx Only
- Manufactured for
ViiV Healthcare RTPNC 27709NDC 49702-228-13
- Lot codes and dates
- Lot
2A9EExp 1/2027
- Lot
- Amount recalled
- 328 bottles
Where it was sold
- Nationwide
Why it was recalled
Labeling: incorrect or missing lot and/or expiration date. An incorrect expiration date was printed on the product labeling with an expiration date of January 2027, whereas the correct expiration date is September 2026.
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new GlaxoSmithKline LLC recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.